Skip to Content
NEW
A vastly improved search engine helps you find the latest on companies, business leaders, and news more easily.
SIGN IN
The biopharmaceutical company makes its debut on the Fortune 500 this year, riding the wave of a 49% year-over-year revenue increase in 2020—driven primarily by its cystic fibrosis drugs Kaftrio and Trikafta.
Lists ranking Vertex Pharmaceuticals
RANK23
100 Fastest-Growing Companies - 2021Collectively, the ranked companies produced a thre...READ MOREview in list
RANK448
Fortune 500 - 2021This year’s Fortune 500 marks the 67th running of ...READ MOREview in list
RANK16
Future 50 - 2020Explore this year's ranking of the 50 companies wi...READ MOREview in list